SI
PFE icon

Sava Infond’s Pfizer PFE Stock Holding History

Sava Infond’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
10,050
-4,550
-31% -$119K 0.02% 178
2026
Q1 		$410K Buy
14,600
+7,300
+100% +$194K 0.06% 150
2025
Q4 		$182K Buy
+7,300
New +$184K 0.02% 176

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

Sava Infond's PFE Position: Q2 2026 in Review

Sava Infond reduced its Pfizer (PFE) stake by 31% in Q2 2026, selling an estimated $119K and leaving 10,050 shares worth $242K. The position accounts for 0.02% of the portfolio, ranked #178.

Sava Infond first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $410K in Q1 2026. 639 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sava Infond held 10,050 shares of Pfizer worth $242K as of Q2 2026.
  • Sava Infond sold 4,550 Pfizer shares in Q2 2026, an estimated $119K.
  • Pfizer made up 0.02% of Sava Infond's portfolio in Q2 2026, its #178 holding.
  • Sava Infond first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Sava Infond's Pfizer position peaked at $410K in Q1 2026.
  • 639 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.